Treatment of nervous system disorders using combinations of rxr agonists and thyroid hormones
US-2025248962-A1 · Aug 7, 2025 · US
This page is not indexed by search engines while we improve data quality.
Io Therapeutics Inc — Cross-Sectional Technologies
Io Therapeutics Inc holds 68 patents in Cross-Sectional Technologies, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Io Therapeutics Inc |
| Technology | Cross-Sectional Technologies |
| Patents in slice | 68 |
| Recent patents in slice | 4 |
| First year | 2015 |
| Last year | 2025 |
Representative patents
Notable publications linking Io Therapeutics Inc to Cross-Sectional Technologies.
Autoimmune disorder treatment using RXR agonists
US-11793781-B2 · Oct 24, 2023 · US
Treatment of autoimmune diseases with combinations of RXR agonists and thyroid hormones
US-11690831-B2 · Jul 4, 2023 · US
Treatment of autoimmune diseases with combinations of RXR agonists and thyroid hormones
US-11690832-B2 · Jul 4, 2023 · US
Treatment of disease with esters of selective rxr agonists
US-2023126763-A1 · Apr 27, 2023 · US
Recent filings
Latest patents from Io Therapeutics Inc in Cross-Sectional Technologies.
Treatment of nervous system disorders using combinations of rxr agonists and thyroid hormones
US-2025248962-A1 · Aug 7, 2025 · US
Autoimmune disorder treatment using RXR agonists
US-11793781-B2 · Oct 24, 2023 · US
Treatment of autoimmune diseases with combinations of RXR agonists and thyroid hormones
US-11690831-B2 · Jul 4, 2023 · US
Treatment of autoimmune diseases with combinations of RXR agonists and thyroid hormones
US-11690832-B2 · Jul 4, 2023 · US
Treatment of disease with esters of selective rxr agonists
US-2023126763-A1 · Apr 27, 2023 · US
Related pages
Navigate to parent entity pages.